We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Sandoz, a Novartis division, has acquired Coalesce Product Development Limited, a UK-based medical and drug delivery device development company. With this transaction, Sandoz has acquired the capabilities and
Fresenius Kabi has secured 510(k) regulatory approval from the US Food and Drug Administration (FDA) for its wireless Agilia Connect Infusion System. This system includes the Agilia Volumetric
US-based Guardant Health has secured regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for Guardant360 CDx, a liquid biopsy test for tumour mutation profiling
Cionic has received FDA approval for its lightweight, leg-worn Neural Sleeve, which has been designed to help people with mobility issues due to multiple sclerosis (MS), stroke, cerebral
Sherlock Biosciences has raised $80m through a Series B financing round to develop CRISPR-based diagnostics. This round was led by Novalis LifeSciences and included new investors Illumina Ventures,
Switzerland-based commercial-stage diagnostics company Quotient has secured Conformité Européenne (CE) Mark for its MosaiQ Extended Immunohematology (IH) Microarray. With this marking, the firm will be able to commercialise